Literature DB >> 23804391

New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance.

Shamira J Shallom1, Paul J Gardina, Timothy G Myers, Yinong Sebastian, Patricia Conville, Leslie B Calhoun, Hervé Tettelin, Kenneth N Olivier, Gulbu Uzel, Elizabeth P Sampaio, Steven M Holland, Adrian M Zelazny.   

Abstract

Mycobacterium abscessus (M. abscessus sensu lato, or the M. abscessus group) comprises three closely related taxa whose taxonomic statuses are under revision, i.e., M. abscessus sensu stricto, Mycobacterium bolletii, and Mycobacterium massiliense. We describe here a simple, robust, and cost-effective PCR-based method for distinguishing among M. abscessus, M. massiliense, and M. bolletii. Based on the M. abscessus ATCC 19977(T) genome, regions that discriminated between M. abscessus and M. massiliense were identified through array-based comparative genomic hybridization. A typing scheme using PCR primers designed for four of these locations was applied to 46 well-characterized clinical isolates comprising 29 M. abscessus, 15 M. massiliense, and 2 M. bolletii isolates previously identified by multitarget sequencing. Interestingly, 2 isolates unequivocally identified as M. massiliense were shown to have a full-length erm(41) gene instead of the expected gene deletion and showed inducible clarithromycin resistance after 14 days. We propose using this PCR-based typing scheme combined with erm(41) PCR for straightforward identification of M. abscessus, M. massiliense, and M. bolletii and the assessment of inducible clarithromycin resistance. This method can be easily integrated into a routine workflow to provide subspecies-level identification within 24 h after isolation of the M. abscessus group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23804391      PMCID: PMC3754618          DOI: 10.1128/JCM.01132-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Authors:  Michelle Pignone; Kimberly M Greth; Jason Cooper; David Emerson; Jane Tang
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  A faster circular binary segmentation algorithm for the analysis of array CGH data.

Authors:  E S Venkatraman; Adam B Olshen
Journal:  Bioinformatics       Date:  2007-01-18       Impact factor: 6.937

Review 4.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

5.  Discrimination of intact mycobacteria at the strain level: a combined MALDI-TOF MS and biostatistical analysis.

Authors:  Justin M Hettick; Michael L Kashon; James E Slaven; Yan Ma; Janet P Simpson; Paul D Siegel; Gerald N Mazurek; David N Weissman
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

6.  Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.

Authors:  R J Wallace; A Meier; B A Brown; Y Zhang; P Sander; G O Onyi; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

7.  A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.

Authors:  Kevin A Nash; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

8.  Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Authors:  Adrian M Zelazny; Jeremy M Root; Yvonne R Shea; Rhonda E Colombo; Isdore C Shamputa; Frida Stock; Sean Conlan; Steven McNulty; Barbara A Brown-Elliott; Richard J Wallace; Kenneth N Olivier; Steven M Holland; Elizabeth P Sampaio
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

Review 9.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates.

Authors:  Hee-Youn Kim; Yoonwon Kook; Yeo-Jun Yun; Chan Geun Park; Nam Yong Lee; Tae Sun Shim; Bum-Joon Kim; Yoon-Hoh Kook
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

View more
  37 in total

1.  Rapid Detection of Acquired and Inducible Clarithromycin Resistance in Mycobacterium abscessus Group by a Simple Real-Time PCR Assay.

Authors:  Robert F Luo; Cheyenne Curry; Nathan Taylor; Indre Budvytiene; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

2.  Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group.

Authors:  Natalia Fernandes Garcia de Carvalho; Daisy Nakamura Sato; Fernando R Pavan; Lucilaine Ferrazoli; Erica Chimara
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

3.  "You can't always get what you want…" the Mycobacterium abscessus issue. Name versus function.

Authors:  Adrian M Zelazny; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2015-03

4.  Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.

Authors:  Isaac Darko Otchere; Adwoa Asante-Poku; Stephen Osei-Wusu; Samuel Yaw Aboagye; Dorothy Yeboah-Manu
Journal:  Int J Mycobacteriol       Date:  2017 Jan-Mar

5.  Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.

Authors:  Barbara A Brown-Elliott; Kimberly Hanson; Sruthi Vasireddy; Elena Iakhiaeva; Kevin A Nash; Ravikiran Vasireddy; Nicholas Parodi; Terry Smith; Martha Gee; Anita Strong; Adam Barker; Samuel Cohen; Haleina Muir; E Susan Slechta; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

6.  Three cases of postoperative septic arthritis caused by Mycobacterium conceptionense in the shoulder joints of immunocompetent patients.

Authors:  Keun Hwa Lee; Sang Taek Heo; Sung-Wook Choi; Da Hee Park; Young Ree Kim; Seung Jin Yoo
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

Review 7.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?

Authors:  Kimberly E Hanson; E Susan Slechta; Haleina Muir; Adam P Barker
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Authors:  Kenneth N Olivier; Pamela A Shaw; Tanya S Glaser; Darshana Bhattacharyya; Michelle Fleshner; Carmen C Brewer; Christopher K Zalewski; Les R Folio; Jenifer R Siegelman; Shamira Shallom; In Kwon Park; Elizabeth P Sampaio; Adrian M Zelazny; Steven M Holland; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 10.  Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.

Authors:  Nopporn Apiwattankul; Patricia M Flynn; Randall T Hayden; Elisabeth E Adderson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-07       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.